XML 31 R18.htm IDEA: XBRL DOCUMENT v3.2.0.727
C. STOCKHOLDERS EQUITY (Tables)
 9 Months Ended
Jun. 30, 2015
C. Stockholders Equity Tables  
Stock options, stock bonuses and compensation granted by the Company

Stock options, stock bonuses and compensation granted by the Company as of June 30, 2015 are as follows:

 

Name of Plan   Total Shares Reserved Under Plans     Shares Reserved for Outstanding Options     Shares Issued as Stock Bonus     Remaining Options/Shares Under Plans  
                         
Incentive Stock Options Plans     1,960,000       1,708,331       N/A       5,969  
Non-Qualified Stock Option Plans     7,680,000       5,829,269       N/A       1,265,979  
Stock Bonus Plans     3,594,000       N/A       1,470,254       2,122,919  
Stock Compensation Plans     3,350,000       N/A       1,316,949       2,000,000  
Incentive Stock Bonus Plan     16,000,000       N/A       15,600,000       400,000  

 

Stock options granted by the Company or forfeited by the holder during the nine and three months ended June 30, 2015 and 2014 are as follows:

 

    Nine Months Ended June 30,  
    2015     2014  
 Granted     803,700       743,040  
 Forfeited     137,249       5,316  

 

    Three Months Ended June 30,  
    2015     2014  
Granted     801,700       -  
Forfeited     27,833       5,316  

 
Schedule of employees and non-employees stock compensation

 

    Nine Months Ended March 31,  
    2015     2014  
 Employees   $ 4,570,999     $ 1,493,134  
 Non-employees   $ 437,729     $ 611,416  

 

    Three Months Ended March 31,  
    2015     2014  
 Employees   $ 619,145     $ 462,705  
 Non-employees   $ 137,600     $ 189,906  
Derivative Liabilities, Warrants and Other Options
Warrant   Issue Date   Shares Issuable upon Exercise of Warrant     Exercise Price   Expiration Date   Refer-ence  
                         
Series H   1/26/12     1,200,000     $ 5.00   8/1/15     1  
Series Q   6/21/12     1,200,000     $ 5.00   12/22/15     1  
Series R   12/6/12     2,625,000     $ 4.00   12/6/16     1  
Series S   10/11/13 -10/24/14     25,928,010     $ 1.25   10/11/18     1  
Series U   4/17/14     445,514     $ 1.75   10/17/17     1  
Series V   5/28/15     20,253,164     $ 0.79   5/28/2020     1  
Series N   8/18/08     2,844,627     $ 0.53   8/18/17     2  
Series P   2/10/12     590,001     $ 4.50   3/6/17     2  
Consultants   10/14/05– 3/30/15     188,000     $ 0.85-$20.00   10/14/15 -3/29/2018     3  
Tabular disclosure of derivative liabilities at fair value
   

June 30,

2015

    

September 30,

2014

  
Series A through E warrants   $ -     $ 6,105  
Series H warrants     -       12,000  
Series Q warrants     -       12,000  
Series R warrants     26,250       157,500  
Series S warrants     5,185,602       5,197,352  
Series U warrants     45,937       120,289  
Series V warrants     6,902,460       -  
                 
Total derivative liabilities   $ 12,160,249     $ 5,505,246  
Schedule Of Gains and (Losses) on Derivative Liabilities

The table below presents the gains and (losses) on the derivative instruments for the nine months ended June 30:

 

    2015     2014  
Series A through E warrants   $ 6,105     $ 1  
Series H warrants     12,000       12,000  
Series N warrants     -       (1,404,027 )
Series Q warrants     12,000       -  
Series R warrants     131,250       52,500  
Series S warrants     472,487       153,814  
Series T warrants     -       115,737  
Series U warrants     74,352       16,220  
Series V warrants     1,100,760       -  
                 
Net gain (loss) on derivative instruments   $ 1,808,954     $ (1,053,755 )

 

The table below presents the gains on the derivative instruments for the three months ended June 30:

 

    2015     2014  
Series A through E warrants   $ -     $ 24,424  
Series F and G warrants     -       36,666  
Series H warrants     12,000       48,000  
Series Q warrants     12,000       72,000  
Series R warrants     105,000       236,250  
Series S warrants     3,111,361       3,918,479  
Series T warrants     -       115,737  
Series U warrants     87,659       16,220  
Series V warrants     1,100,760       -  
                 
Net gain on derivative instruments   $ 4,428,780     $ 4,467,776